Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-05

Clinical Trial Update: Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and tolerability of intravenous carbamazepine in adults with epilepsy completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

Sponsor: Lundbeck LLC | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2016-12-05